MaxLinear (MXL) PT Lowered to $34 at Needham & Company
Tweet
Share
E-mailGet Alerts MXL Hot Sheet
Price: $66.77 +0.51%
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Needham & Company analyst N. Quinn Bolton lowered the price target on MaxLinear (NASDAQ: MXL) to $34.00 (from $48.00) while maintaining a Buy rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Hesai (2525:HK) (HSAI) PT Lowered to HK$24.20 at Macquarie
- Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
